FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3206989315> ?p ?o ?g. }

• W3206989315 endingPage "1223" @default.
• W3206989315 startingPage "1217" @default.
• W3206989315 abstract "Practical laboratory proxies that correlate to vaccine efficacy may facilitate trials, identify nonresponders, and inform about boosting strategies. Among clinical and laboratory markers, assays that evaluate antibodies that inhibit receptor-binding domain (RBD) ligation to angiotensin-converting enzyme-2 receptor (receptor-binding inhibition [RBI]) may provide a surrogate for viral neutralization assays. We evaluated RBI before and after a median of 34 days (interquartile range [IQR]: 33-40) of the second dose of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Sinovac's CoronaVac (CN) or AstraZeneca/Oxford's AZD1222 (AZ) vaccines in 166 individuals. Both vaccines elicited high inhibitory titers in most subjects, 95% (158/166), with signal inhibition above 30% and 89% (127/143) with more than fourfold increase from prevaccination titers, but titers tend to decrease over time. Both postvaccination inhibitory titers (95%, IQR 85%-97% for AZ vs. 79%, IQR 60%-96% for CN, p = 0.004) and pre/post-titer increase (AZ 76%, IQR 51%-86% for AZ vs. 47%, IQR 24%-67% for CN, p < 0.0001) were higher among AZ vaccinees. Previous serological reactivity due to natural infection was associated with high prevaccination signal inhibition titers. The study documents a robust antibody response capable of interfering with RBD-angiotensin-converting enzyme binding. Evaluation of SARS-CoV-2 infection incidence in these populations is necessary to assess its association to protection and its duration." @default.
• W3206989315 created "2021-10-25" @default.
• W3206989315 creator A5003314166 @default.
• W3206989315 creator A5010985259 @default.
• W3206989315 creator A5017896556 @default.
• W3206989315 creator A5022194723 @default.
• W3206989315 creator A5037900121 @default.
• W3206989315 creator A5039637794 @default.
• W3206989315 creator A5040244465 @default.
• W3206989315 creator A5042096843 @default.
• W3206989315 creator A5056510091 @default.
• W3206989315 creator A5079874543 @default.
• W3206989315 date "2021-10-20" @default.
• W3206989315 modified "2023-10-18" @default.
• W3206989315 title "Inhibition of receptor‐binding domain—ACE2 interaction after two doses of Sinovac's CoronaVac or AstraZeneca/Oxford's AZD1222 SARS‐CoV‐2 vaccines" @default.
• W3206989315 cites W3001195213 @default.
• W3206989315 cites W3044482768 @default.
• W3206989315 cites W3087185517 @default.
• W3206989315 cites W3088489318 @default.
• W3206989315 cites W3100210861 @default.
• W3206989315 cites W3118864362 @default.
• W3206989315 cites W3120285103 @default.
• W3206989315 cites W3130184808 @default.
• W3206989315 cites W3135260899 @default.
• W3206989315 cites W3162622073 @default.
• W3206989315 cites W3163785571 @default.
• W3206989315 cites W3166802659 @default.
• W3206989315 cites W3206989315 @default.
• W3206989315 doi "https://doi.org/10.1002/jmv.27396" @default.
• W3206989315 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34647623" @default.
• W3206989315 hasPublicationYear "2021" @default.
• W3206989315 type Work @default.
• W3206989315 sameAs 3206989315 @default.
• W3206989315 citedByCount "5" @default.
• W3206989315 countsByYear W32069893152021 @default.
• W3206989315 countsByYear W32069893152022 @default.
• W3206989315 countsByYear W32069893152023 @default.
• W3206989315 crossrefType "journal-article" @default.
• W3206989315 hasAuthorship W3206989315A5003314166 @default.
• W3206989315 hasAuthorship W3206989315A5010985259 @default.
• W3206989315 hasAuthorship W3206989315A5017896556 @default.
• W3206989315 hasAuthorship W3206989315A5022194723 @default.
• W3206989315 hasAuthorship W3206989315A5037900121 @default.
• W3206989315 hasAuthorship W3206989315A5039637794 @default.
• W3206989315 hasAuthorship W3206989315A5040244465 @default.
• W3206989315 hasAuthorship W3206989315A5042096843 @default.
• W3206989315 hasAuthorship W3206989315A5056510091 @default.
• W3206989315 hasAuthorship W3206989315A5079874543 @default.
• W3206989315 hasBestOaLocation W32069893151 @default.
• W3206989315 hasConcept C119060515 @default.
• W3206989315 hasConcept C126322002 @default.
• W3206989315 hasConcept C159047783 @default.
• W3206989315 hasConcept C159654299 @default.
• W3206989315 hasConcept C170493617 @default.
• W3206989315 hasConcept C203014093 @default.
• W3206989315 hasConcept C22889606 @default.
• W3206989315 hasConcept C2776090121 @default.
• W3206989315 hasConcept C2779053233 @default.
• W3206989315 hasConcept C2779134260 @default.
• W3206989315 hasConcept C3007834351 @default.
• W3206989315 hasConcept C3008058167 @default.
• W3206989315 hasConcept C32611913 @default.
• W3206989315 hasConcept C45189115 @default.
• W3206989315 hasConcept C524204448 @default.
• W3206989315 hasConcept C71924100 @default.
• W3206989315 hasConcept C8891405 @default.
• W3206989315 hasConceptScore W3206989315C119060515 @default.
• W3206989315 hasConceptScore W3206989315C126322002 @default.
• W3206989315 hasConceptScore W3206989315C159047783 @default.
• W3206989315 hasConceptScore W3206989315C159654299 @default.
• W3206989315 hasConceptScore W3206989315C170493617 @default.
• W3206989315 hasConceptScore W3206989315C203014093 @default.
• W3206989315 hasConceptScore W3206989315C22889606 @default.
• W3206989315 hasConceptScore W3206989315C2776090121 @default.
• W3206989315 hasConceptScore W3206989315C2779053233 @default.
• W3206989315 hasConceptScore W3206989315C2779134260 @default.
• W3206989315 hasConceptScore W3206989315C3007834351 @default.
• W3206989315 hasConceptScore W3206989315C3008058167 @default.
• W3206989315 hasConceptScore W3206989315C32611913 @default.
• W3206989315 hasConceptScore W3206989315C45189115 @default.
• W3206989315 hasConceptScore W3206989315C524204448 @default.
• W3206989315 hasConceptScore W3206989315C71924100 @default.
• W3206989315 hasConceptScore W3206989315C8891405 @default.
• W3206989315 hasIssue "3" @default.
• W3206989315 hasLocation W32069893151 @default.
• W3206989315 hasLocation W32069893152 @default.
• W3206989315 hasLocation W32069893153 @default.
• W3206989315 hasOpenAccess W3206989315 @default.
• W3206989315 hasPrimaryLocation W32069893151 @default.
• W3206989315 hasRelatedWork W1984647379 @default.
• W3206989315 hasRelatedWork W2025210812 @default.
• W3206989315 hasRelatedWork W2029098033 @default.
• W3206989315 hasRelatedWork W2381991529 @default.
• W3206989315 hasRelatedWork W2414181163 @default.
• W3206989315 hasRelatedWork W3036305013 @default.
• W3206989315 hasRelatedWork W3127693599 @default.
• W3206989315 hasRelatedWork W4210401150 @default.
• W3206989315 hasRelatedWork W4225282409 @default.

• next